Anna Pan, PharmD, PGY1 pharmacy resident, Kaiser Permanente, discusses a study in which she and coinvestigators analyzed the incidence of cardiovascular complications in patients with type 2 diabetes receiving either GLP-1 receptor agonists...
Anna Pan, PharmD, PGY1 pharmacy resident, Kaiser Permanente, discusses a study in which she and coinvestigators analyzed the incidence of cardiovascular complications in patients with type 2 diabetes receiving either GLP-1 receptor agonists...
Anna Pan, PharmD, PGY1 pharmacy...